Perry v. Insys Therapeutics, Inc.
| Colleen Perry |
| Insys Therapeutics, Inc. |
| 1:2018cv01190 |
| December 19, 2018 |
| US District Court for the District of New Hampshire |
| Joseph A DiClerico |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1441 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 14, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
ENDORSED ORDER granting #7 Assented to Motion to Extend Time to Answer re #1 Notice of Removal. Text of Order: Motion to Extend Time to Answer is granted. For the reasons stated in the motion, the court finds good cause to extend the deadline for issuing the scheduling order pursuant to Fed. R. Civ. P. 16(b). So Ordered by Judge Joseph A. DiClerico, Jr. Answer Follow Up on 2/25/2019. (ko)
|
| Filing 7 Assented to MOTION to Extend Time to Answer to 45 days filed by Insys Therapeutics, Inc..(Ramsdell, Michael) |
|
ENDORSED ORDER granting #5 Assented to MOTION for David J. Walz to Appear Pro Hac Vice ; granting #6 Assented to MOTION for Adam P. Schwartz to Appear Pro Hac Vice. Text of Order: Granted on the condition that David J. Walz and Adam P. Schwartz submit an ECF registration form within 10 days. Local counsel shall comply with all obligations required by L.R. 83.2(b) absent order of the court. So Ordered by Magistrate Judge Andrea K. Johnstone. ECF Registration Deadline set for 2/1/2019.To access the online registration form, click #HERE. Persons filing electronically are strongly encouraged to complete the interactive training modules available on the courts website. To access these modules, click #HERE.(ko)
|
| Filing 6 Assented to MOTION for Adam P. Schwartz to Appear Pro Hac Vice (Filing fee $ 100, Receipt # 0102-1760189.) filed by Insys Therapeutics, Inc.. (Attachments: #1 Exhibit (Affidavit))(Ramsdell, Michael) |
| Filing 5 Assented to MOTION for David J. Walz to Appear Pro Hac Vice (Filing fee $ 100, Receipt # 0102-1760175.) filed by Insys Therapeutics, Inc.. (Attachments: #1 Exhibit (Affidavit))(Ramsdell, Michael) |
|
ENDORSED ORDER granting #3 Motion to Extend Time to Answer. Text of Order: Motion to Extend Time to Answer is granted. For the reasons stated in the motion, the court finds good cause to extend the deadline for issuing the scheduling order pursuant to Fed. R. Civ. P. 16(b). So Ordered by Judge Joseph A. DiClerico, Jr. Answer Follow Up on 2/11/2019. The court only follow up date DOES NOT include 3 additional days that may apply per FRCP 6(d) and FRCrP 45(c).(gla)
|
| Filing 4 Certified Copies of State Court Record. State Court Case No. 219-2018-CV-00398, Strafford County Superior Court(Ramsdell, Michael) |
| Filing 3 Assented to MOTION to Extend Time to Answer for 30 Days filed by Insys Therapeutics, Inc..(Ramsdell, Michael) |
| NOTICE. This case has been designated for Electronic Case Filing. All further submissions shall be filed in compliance with the Administrative Procedures for Electronic Case Filing. Pro se litigants are not required to file electronically and may continue to file documents in paper format. Persons filing electronically are strongly encouraged to complete the interactive training modules available on the courts website. To access these modules, click #HERE. Pursuant to Local Rule 81.1(a) and (b), answers and motions filed in the state court will not be considered unless refiled in this court. Please note that all filings in this District must comply with Local Rule 7. The Local Rules and Administrative Procedures for ECF can be downloaded from our website #HERE.(ej) |
| Case assigned to Judge Joseph A. DiClerico, Jr. The case designation is: 1:18-cv-1190-JD. Please show this number with the judge designation on all future pleadings. (ej) |
| Filing 2 Disclosure Statement by Insys Therapeutics, Inc. disclosing no parent company, no publicly traded company, and no merger agreement. (Ramsdell, Michael) |
| Filing 1 NOTICE OF REMOVAL with Jury Demand from Strafford Superior Court, case number 219-2018-cv-00398 (filing fee $400, receipt number 0102-1747598) filed by Insys Therapeutics, Inc.. Answer Follow Up on 1/9/2019. The court only follow up date DOES NOT include 3 additional days that may apply per FRCP 6(d) and FRCrP 45(c). State Court Record Follow Up 1/2/2019. (Attachments: #1 Summons, #2 Summons, #3 Notice to Plaintiff of Removal, #4 Notice to State Court Clerk, #5 Civil Cover Sheet)(Ramsdell, Michael) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Hampshire District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Perry v. Insys Therapeutics, Inc. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Colleen Perry | |
| Represented By: | Michael P. Rainboth |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Insys Therapeutics, Inc. | |
| Represented By: | Michael D. Ramsdell |
| Represented By: | David J. Walz |
| Represented By: | Adam P. Schwartz |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
